Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity
Crossref DOI link: https://doi.org/10.1007/s00280-014-2613-7
Published Online: 2014-10-28
Published Print: 2015-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Levinsen, Mette
Rosthøj, Susanne
Nygaard, Ulrikka
Heldrup, Jesper
Harila-Saari, Arja
Jonsson, Olafur G.
Bechensteen, Anne Grete
Abrahamsson, Jonas
Lausen, Birgitte
Frandsen, Thomas L.
Weinshilboum, Richard M.
Schmiegelow, Kjeld
Text and Data Mining valid from 2014-10-28